NMRA vs OVID

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 08, 2026

NMRA

31.2
AI Score
VS
OVID Wins

OVID

38.5
AI Score

Investment Advisor Scores

NMRA

31score
Recommendation
AVOID NEW MONEY

OVID

39score
Recommendation
EXTENDED

AI Analyst Insights

Detailed Metrics Comparison

Metric NMRA OVID Winner
Forward P/E 0 1.7918 Tie
PEG Ratio 0 0 Tie
Revenue Growth 0.0% -88.3% NMRA
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 31.2/100 38.5/100 OVID
Profit Margin 0.0% 0.0% Tie
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY EXTENDED OVID

Relative Price Performance (Last 90 Days)

NMRA 1M: +6.7% · 3M: -72.7% OVID 1M: +16.2% · 3M: +6.9%

Current Technical Phase

NMRA

Markdown
Sell / avoid

Price below a falling SMA50 (slope -40.9%), weak momentum, RSI 44

RSI (14): 44.3 · Price: $0.47

OVID

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 60

RSI (14): 60.4 · Price: $2.80

Fundamentals Snapshot

Metric NMRA OVID
Market Cap — —
Forward P/E -0.7 -7.6
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.0% -0.9%
Gross Margin — 1.0%
Operating Margin 0.0% -21.0%
EPS -1.20 -0.22
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, OVID is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.